Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 02/21 10:02:38 pm
35.76 USD   -0.69%
02/20PFIZER : WINDOM - Dennis R
AQ
02/20PFIZER : Merck kgaa, darmstadt, germany, and pfizer provide update o..
AQ
02/19UK shares retreat as Reckitt disappoint
RE
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/14/2018 02/15/2018 02/16/2018 02/20/2018 02/21/2018 Date
35.19(c) 35.71(c) 36.26(c) 36.01(c) 35.76(c) Last
23 239 837 21 431 059 26 242 465 25 808 704 23 958 191 Volume
+0.72% +1.48% +1.54% -0.69% -0.69% Change
More quotes
Financials ($)
Sales 2018 54 410 M
EBIT 2018 20 806 M
Net income 2018 13 101 M
Debt 2018 22 213 M
Yield 2018 3,79%
Sales 2019 54 778 M
EBIT 2019 21 557 M
Net income 2019 13 766 M
Debt 2019 16 230 M
Yield 2019 4,00%
P/E ratio 2018 16,53
P/E ratio 2019 15,38
EV / Sales2018 4,38x
EV / Sales2019 4,24x
Capitalization 216 B
More Financials
Company
Pfizer, Inc. engages in the manufacture of vaccines and injectable biologic medicines.It operates through the Pfizer Innovative Health and Pfizer Essential Health segments.The Pfizer Innovative Health segment focuses on developing and commercializing novel, value-creating medicines, and vaccines... 
Sector
Pharmaceuticals
Calendar
05/01Earnings Release
More about the company
Surperformance© ratings of Pfizer
Trading Rating : Investor Rating :
More Ratings
Latest news on PFIZER
07:08pPFIZER : announces resignation of ED cum CFO
AQ
09:17aPFIZER : Factory Mutual Insurance Company Increases Stake in Pfizer (PFE); As Pf..
AQ
02/20PFIZER : WINDOM - Dennis R
AQ
02/20PFIZER : Merck kgaa, darmstadt, germany, and pfizer provide update on phase iii ..
AQ
02/19UK shares retreat as Reckitt disappoint
RE
02/19Reckitt shares sink on missed profit, vague outlook
RE
02/19Stocks mostly up
AQ
02/17PFIZER : Avelumab Falls Short in Phase III NSCLC Trial
AQ
02/17Merck/Pfizers cancer immunotherapy latecomer hits a snag
AQ
02/16DOW MOVERS : Mcd, csco
AQ
More news
Sector news : Pharmaceuticals - NEC
02:39pMERCK : to Invest Additional EUR40 Million in Asia
DJ
02:15pMerck to buy virus-based cancer drug firm Viralytics for $394 million
RE
12:27pMERCK AND : to Buy Australia's Viralytics for $394 Million
DJ
08:48aNOVARTIS : Builds Up R&D -- WSJ
DJ
08:48aABBVIE : FTC Clout Tested in Suit Versus Drugmaker -- WSJ
DJ
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on PFIZER 
PFIZER INC. - 2016
Expectation of a turn-around
BUY
PFIZER INC. - 2016
Back on a long term support level
BUY
More Strategies
Latest Tweets
07:23p$FLCR Fact INSIDERS OWN 40% OF THE FLOAT! $AAPL $GOOG $INTC $AMZN $MSFT $AKAM.. 
04:12pAnd.... Top Pfizer research exec John Davis joins migration to biotech, lands..
3
03:28pPharmalot.. Pharmalittle.. Good Morning.. headlines & coffee are served.... 
01:14pGet the latest ratings for $ATTU $FFG $FOGO $PFE $ANY in your inbox with Mark.. 
12:43pThe top 15 R&D spenders in global drug R&D — late-stage profiles on: ..
6
More tweets
Qtime:470
News from SeekingAlpha
03:22aCORIUM INTERNATIONAL : Will This Stellar Growth Company Continue To Deliver Prof.. 
02/20BIOTECHS : Still Well Placed For More Gains 
02/202018 Brings New Challenges And Opportunities For Alnylam Pharmaceuticals 
02/20FDA tentatively OKs Mylan's HIV combo pill 
02/173 THINGS IN BIOTECH YOU SHOULD LEARN : February 17, 2018 
Chart PFIZER
Duration : Period :
Pfizer Technical Analysis Chart | PFE | US7170811035 | 4-Traders
Technical analysis trends PFIZER
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 40,3 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Ian C. Read Chairman & Chief Executive Officer
Albert Bourla Chief Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Business Operations
Freda C. Lewis-Hall Chief Medical Officer & Executive Vice President
Mikael Dolsten President-Worldwide Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PFIZER-2.84%216 135
JOHNSON & JOHNSON-7.19%357 710
NOVARTIS-3.37%226 667
ROCHE HOLDING LTD.-9.37%207 826
MERCK AND COMPANY-0.50%153 359
AMGEN3.23%132 827